What is the dosage of Pemazyre?

Pemazyre is available in 3 dosages, including 13.5 mg Tab, 4.5 mg Tab and 9 mg Tab

What does Pemazyre treat?

Pemazyre treats Cholangiocarcinoma

What is Pemazyre made of?

Pemazyre contains pemigatinib which is a undefined

How is Pemazyre administered?

Pemazyre is administered as a Oral Pill

What is Pemazyre mechanism of action?

Pemazyre mechanism of action is

Dosage & Administration Drug label Samples Prior authorization Financial assistance

Patient education

Pemazyre

(pemigatinib)

pemigatinib 13.5 MG Oral Tablet [Pemazyre]pemigatinib 4.5 MG Oral Tablet [Pemazyre]

View 1 more

NO BLACK BOX WARNING

Dosage & administration

Cholangiocarcinoma:

* Confirm the presence of an FGFR2 fusion or rearrangement prior to initiation of treatment with PEMAZYRE.
* Recommended dosage is 13.5 mg orally once daily for 14 consecutive days followed by 7 days off therapy in 21-day cycles. Continue treatment until disease progression or unacceptable toxicity occurs.

Myeloid/lymphoid neoplasms with FGFR1 rearrangement:

* Recommended dosage is 13.5 mg orally once daily. Continue treatment until disease progression or unacceptable toxicity.

All patients treated with PEMAZYRE:

* Swallow tablet whole, with or without food.
* Severe Renal Impairment: the recommended dosage of PEMAZYRE is 9 mg with the schedule (intermittent or continuous) designated for the indication.
* Severe Hepatic Impairment: the recommended dosage of PEMAZYRE is 9 mg with the schedule (intermittent or continuous) designated for the indication.

drug label

Pemazyre prescribing information

Have more Pemazyre questions?

Submit MSL Request

Learn More

Need to report a Pemazyre issue?

ONLINE FORMReport adverse event

Learn More

samples

Request Pemazyre samples

NOT PROVIDED BY BRANDView Online Sample Form

Learn More

prior authorization

Pemazyre Prior authorization resources

Complete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

Coverage Authorization Appeals

Learn More

Benefits investigation

IncyteCARES for Pemazyre Enrollment Form

IncyteCARES for Pemazyre Enrollment Form - Online

Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information

Learn More

financial assistance

Pemazyre Financial assistance options

Co-pay savings program

commercial only

IncyteCARES for Pemazyre Enrollment Form

IncyteCARES for Pemazyre Enrollment Form - Online

Enroll in Patient Savings Program - HCP Office

Enroll in Patient Savings Program - Patient

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

IncyteCARES for Pemazyre Enrollment Form

IncyteCARES for Pemazyre Enrollment Form - Online

IncyteCARES for Pemazyre Temporary Access Program

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

IncyteCARES for Pemazyre Enrollment Form

IncyteCARES for Pemazyre Enrollment Form - Online

IncyteCARES for Pemazyre Patient Assistance Program

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Pemazyre Patient education

Getting started on Pemazyre

NOT PROVIDED BY BRANDInstructions For Use: Metastatic Cholangiocarcinoma with FGFR2 Fusion

NOT PROVIDED BY BRANDInstructions For Use: Myeloid/Lymphoid Neoplasms